SPRING, Texas, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Io Therapeutics, Inc., a privately held pharmaceutical company headquartered in Spring, Texas; announced today presentation at the San Antonio Breast Cancer Symposium, in San Antonio, TX; of data ...
Read MoreADELAIDE, Australia, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Avance Clinical, the award-winning global CRO for biotechs, has announced the launch of its new Diversity in STEM Scholarships , a global initiative designed to support women and ...
Read MoreNew Website: https://gcls.ai GENEVA, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The Geneva College of Longevity Science (GCLS) , in partnership with DrVibe.ai , today announced the launch of the GCLS AI Academy for Longevity Sciences —the ...
Read MoreEXECUTIVE SUMMARY VALLAURIX Research, Development & Innovation Centre to expand its existing facilities and capabilities core focus on accelerating development of liquid long-acting drug delivery platforms existing RD&I teams will advance ...
Read MorePR Newswire SOUTH SAN FRANCISCO, Calif., Dec. 10, 2025 SOUTH SAN FRANCISCO, Calif., Dec. 10, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a leading precision medicine oncology company, announced the submission of an ...
Read MorePR Newswire HONG KONG, Dec. 10, 2025 -Denifanstat (ASC40) met all primary, key secondary and secondary efficacy endpoints (ITT analysis) and significantly improved moderate-to-severe acne vulgaris compared with placebo in a randomized, ...
Read MorePR Newswire SAN FRANCISCO and SUZHOU, China, Dec. 9, 2025 SAN FRANCISCO and SUZHOU, China, Dec. 9, 2025 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures ...
Read MorePR Newswire DUBLIN, Dec. 9, 2025 DUBLIN, Dec. 9, 2025 /PRNewswire/ -- ProVerum Limited, a medical device company focused on innovative, safe and effective solutions for treating benign prostatic hyperplasia (BPH), today announced it has ...
Read MorePR Newswire LAS VEGAS, Dec. 9, 2025 The amyotrophic lateral sclerosis market is expected to grow owing to the increasing prevalence of the disease, along with the promising emerging pipeline therapies, such as Masitinib (AB Sciences), PrimeC ...
Read MorePR Newswire SINGAPORE, Dec. 9, 2025 SINGAPORE, Dec. 9, 2025 /PRNewswire/ -- Immortal Dragons, the $40 million longevity-focused innovation fund, today announced its strategic investment in Etheros, a research-driven technology company ...
Read MorePR Newswire GRAND RAPIDS, Mich., Dec. 9, 2025 Data from Phase 2 Trials Underscore Cardioprotective Potential GRAND RAPIDS, Mich., Dec. 9, 2025 /PRNewswire/ -- Cirius Therapeutics, Inc., a developer of innovative therapies for people ...
Read MorePR Newswire SACRAMENTO, Calif., Dec. 9, 2025 Evolve Releases Landmark White Paper on California's Home Modification Outcomes — Delivering a New Blueprint for Lower Healthcare Costs, Better Patient Outcomes, and Stronger Health Plan ...
Read MorePR Newswire WASHINGTON, Dec. 9, 2025 Speakers explore how we can better protect the heroes who protect us all. WASHINGTON, Dec. 9, 2025 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer ...
Read MorePR Newswire NOVATO, Calif., Dec. 9, 2025 NOVATO, Calif., Dec. 9, 2025 /PRNewswire/ -- Brayton Purcell LLP announces that the California Department of Public Health (CDPH) has issued a critical health advisory in response to a dramatic rise ...
Read MorePR Newswire SAN DIEGO, Dec. 9, 2025 SAN DIEGO, Dec. 9, 2025 /PRNewswire/ -- Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development in oncology, announced that they will ...
Read More
MEDINDIA
English
हिन्दी
Español
français
中文